Dreher, PC, Edwards, D, Hager, S, et al. Complications of the neovagina in male-to-female transgender surgery: a systematic review and meta-analysis with discussion of management. Clin Anat 2018;31(2):191–199.Google Scholar

Horbach, SE, Bouman, MB, Smit, JM, et al. Outcome of vaginoplasty in male-to-female transgenders: a systematic review of surgical techniques. J Sex Med 2015;12(6):1499–1512.Google Scholar

Pendergrass, PB, Reeves, CA, Belovicz, MW, Molter, DJ, White, JH. Comparison of vaginal shapes in Afro-American, Caucasian and Hispanic women as seen with vinyl polysiloxane casting. Gynecol Obstet Invest 2000;50(1):54–59. https://doi.org/10.1159/000010281. PMID 10895030. S2CID 37395321Google Scholar

Slater, MW, Vinaja, X, Aly, I, et al. Neovaginal construction with pelvic peritoneum: reviewing an old approach for a new application. Clin Anat 2018;31(2):175–180.CrossRefGoogle ScholarPubMed

Levy, JA, Edwards, DC, Cutruzzula-Dreher, P, et al. Male-to-female gender reassignment surgery: an institutional analysis of outcomes, short-term complications, and risk factors for 240 patients undergoing penile-inversion vaginoplasty. Urology 2019;131:228–233.CrossRefGoogle ScholarPubMed

Chen, ML, Reyblat, P, Poh, MM, Chi, AC. Overview of surgical techniques in gender-affirming genital surgery. Transl Androl Urol 2019;8(3):191–208.Google Scholar

Ferrando, CA. Vaginoplasty complications. Clin Plast Surg 2018;45(3):361–368.CrossRefGoogle ScholarPubMed

Mukai, Y, Watanabe, T, Sugimoto, M, Kimata, Y, Namba, Y. Vaginoplasty with a pudendal-groin flap in male-to-female transsexuals. Acta Med Okayama 2017;71(5):399–405.Google Scholar

Selvaggi, G, Bellringer, J. Gender reassignment surgery: an overview. Nat Rev Urol 2011;8(5):274–282.CrossRefGoogle ScholarPubMed

Lawrence, AA. Patient-reported complications and functional outcomes of male-to-female sex reassignment surgery. Arch Sex Behav 2006;35(6):717–727.CrossRefGoogle ScholarPubMed

Gaither, TW, Awad, MA, Osterberg, EC, et al. Postoperative complications following primary penile inversion vaginoplasty among 330 male-to-female transgender patients. J Urol 2018;199(3):760–765.Google Scholar

Ives, GC, Fein, LA, Finch, L et al. Evaluation of BMI as a risk factor for complications following gender-affirming penile inversion vaginoplasty. Plast Reconstr Surg Glob Open 2019;7(3):e2097.Google Scholar

Amies Oelschlager, AM, Kirby, A, Breech, L. Evaluation and management of vaginoplasty complications. Curr Opin Obstet Gynecol 2017;29(5):316–321.Google Scholar

Leong, A. Sexual dimorphism of the pelvic architecture: a struggling response to destructive and parsimonious forces by natural & mate selection. Mcgill J Med 2006;9(1):61–66.Google Scholar

Raigosa, M, Avvedimento, S, Yoon, TS, et al. Male-to-female genital reassignment surgery: a retrospective review of surgical technique and complications in 60 patients. J Sex Med 2015;12(8):1837–1845.Google Scholar

Li, JS, Crane, CN, Santucci, RA. Vaginoplasty tips and tricks [published online ahead of print, 2020 Aug 25]. Int Braz J Urol 2020;46. https://doi.org/10.1590/S1677-5538.IBJU.2020.0338Google Scholar

Perovic, S, Djinovic, R. Genitoplasty in male-to-female transsexuals. Curr Opin Urol 2009;19(6):571–576.Google Scholar

Haedersdal, M, Matzen, P, Wulf, HC-More. Laserepilering: En systematisk oversigt over evidensbaserede kliniske resultater [Laser epilation: a systematic review of evidence-based clinical results]. Ugeskrift for laeger 2000;162(50):6809–6815.Google Scholar

Pariser, JJ, Kim, N. Transgender vaginoplasty: techniques and outcomes. Transl Androl Urol 2019;8(3):241–247.Google Scholar

Greaves, NS, Iqbal, SA, Hodgkinson, T, et al. Skin substitute-assisted repair shows reduced dermal fibrosis in acute human wounds validated simultaneously by histology and optical coherence tomography. Wound Repair Regen 2015;23(4):483–494.Google Scholar

Snyder, DL, Sullivan, N, Schoelles, KM. Skin Substitutes for Treating Chronic Wounds [Internet]. Rockville, MD: Agency for Healthcare Research and Quality (US); December 18, 2012. AHRQ Technology Assessments. PMID: 25356454 NBK248353Google Scholar

Drinane, JJ, Santucci, R. What urologists need to know about male to female genital confirmation surgery (vaginoplasty): techniques, complications and how to deal with them. Minerva Urol Nefrol 2020;72(2):162–172.CrossRefGoogle Scholar

Sheikh, ES, Sheikh, ES, Fetterolf, DE. Use of dehydrated human amniotic membrane allografts to promote healing in patients with refractory non healing wounds. Int Wound J 2014;11(6):711–717.Google Scholar

Davydov, SN. Colpopoeisis from the peritoneum of the uterorectal space. Akusherstvo i ginekologiia 1969;45(12):55.Google Scholar

Wroblewski, P, Gustafsson, J, Selvaggi, G. Sex reassignment surgery for transsexuals. Curr Opin Endocrinol Diabetes Obes 2013;20(6):570–574.Google Scholar

Grimes, MD, Tesdahl, BA, Schubbe, M, et al. Histopathology of anterior urethral strictures: toward a better understanding of stricture pathophysiology. J Urol 2019;202(4):748–756.CrossRefGoogle Scholar

Boas, SR, Ascha, M, Morrison, SD, et al. Outcomes and predictors of revision labiaplasty and clitoroplasty after gender-affirming genital surgery. Plast Reconstr Surg 2019;144(6):1451–1461.Google Scholar

Li, FY, Xu, YS, Zhou, CD, et al. Long-term outcomes of vaginoplasty with autologous buccal micromucosa. Obstet Gynecol 2014;123(5):951–956.Google Scholar

Gupta, A, Francis, S, Stewart, R, Hobson, D, Meriwether, KV. Repair of colonic neovaginal stenosis using a biological graft in a male-to-female transgender patient. Int Urogynecol J 2019;30(4):661–663.Google Scholar

van der Sluis, W, Bouman, M-B, Buncamper, M, et al. Clinical characteristics and management of neovaginal fistulas after vaginoplasty in transgender women. Obstet Gynecol 2016;127(6):1118–1126. https://doi.org/10.1097/AOG.0000000000001421Google Scholar

Crisp, CC, Vaccaro, CM, Estanol, MV, et al. Intra-vaginal diazepam for high-tone pelvic floor dysfunction: a randomized placebo-controlled trial. Int Urogynecol J 2013;24:1915–1923.Google Scholar

Holland, MA, Joyce, JS, Brennaman, LM, et al. Intravaginal diazepam for the treatment of pelvic floor hypertonic disorder: a double-blind, randomized, placebo-controlled trial. Female Pelvic Med Reconstr Surg 2019;25(1):76–81.Google Scholar

Bustos, VP, Bustos, SS, Mascaro, A, et al. Regret after gender-affirmation surgery: a systematic review and meta-analysis of prevalence. Plast Reconstr Surg Glob Open 2021;9(3):e3477.Google Scholar

Weijmar Schultz, W, Basson, R, Binik, Y, et al. Women’s sexual pain and its management. J Sex Med 2005;2(3):301–316.Google Scholar

Poone, S, Geolani, WD, Dugi, D. Neovaginal canal dissection in gender affirming vaginoplasty. J Urol 2021; 205(4);1110–1118.Google Scholar

Kuhn, A, Hiltebrand, R, Birkhäuser, M. Do transsexuals have micturition disorders? Eur J Obstet Gynecol Reprod Biol 2007;131(2):226–230.Google Scholar

Hoebeke, P, Selvaggi, G, Ceulemans, P, et al. Impact of sex reassignment surgery on lower urinary tract function. Eur Urol 2005;47(3):398–402.Google Scholar

Valkenet, K, van de IG, Dronkers, JJ, et al. The effects of preoperative exercise therapy on postoperative outcome: a systematic review. Clin Rehab 2011;25(2):99–111.Google Scholar

Wallis, JA, Taylor, NF. Pre-operative interventions (non-surgical and non-pharmacological) for patients with hip or knee osteoarthritis awaiting joint replacement surgery – a systematic review and meta-analysis. Osteoarthr Cartil 2011;19(12):1381–1395.Google Scholar

Saliyan, A, Ozbas, A. The effect of pelvic floor muscle training on incontinence problems after radical prostatectomy. Am J Mens Health 2018;12(4):1007–1015.Google Scholar

Tienforti, D, Sacco, E, Marangi, F, et al. Efficacy of an assisted low‐intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial. BJU Int 2012;110(7):1004–1010.Google Scholar

Jarvis, SK, Hallam, TK, Lujic, S, Abbott, JA, Vancaillie, TG. Peri-operative physiotherapy improves outcomes for women undergoing incontinence and or prolapse surgery: results of a randomised controlled trial. Aust N Z J Obstet Gynaecol 2005;45(4):300–302.Google Scholar

Nauman, K, Stolzle, A, Owens, L, Frilot, CF 2nd, Gomelsky, A. Impact of preoperative pelvic floor muscle training (pretraining) on urinary storage and emptying symptoms in women undergoing sling surgery. Int Urogynecol J 2021;33(3):673–679.Google Scholar

Manrique, OJ, Adabi, K, Huang, TCT, et al. Assessment of pelvic floor anatomy for male-to-female vaginoplasty and the role of physical therapy on functional and patient-reported outcomes. Ann Plast Surg 2018;82(6):661–666.CrossRefGoogle Scholar

Jiang, DD, Gallagher, S, Burchill, L, Berli, J, Dugi, D. Implementation of a pelvic floor physical therapy program for transgender women undergoing gender-affirming vaginoplasty. Obstet Gynecol 2019;133(5):1003–1011.CrossRefGoogle ScholarPubMed

Frawley, H, Shelly, B, Morin, M, et al. An International Continence Society (ICS) report on the terminology for pelvic floor muscle assessment. Neurourol Urodynam 2021;40(5):1217–1260.CrossRefGoogle ScholarPubMed

Center for Substance Abuse Treatment (US). Trauma-Informed Care in Behavioral Health Services. Rockville, MD: Substance Abuse and Mental Health Services Administration (US); Published 2014. (Treatment Improvement Protocol (TIP) Series, No. 57.) PMID: 24901203.Google Scholar

James, SE, Herman, JL, Rankin, S, et al. The Report of the 2015 U.S. Transgender Survey. Washington, DC: National Center for Transgender Equality. Published 2016. See: https://transequality.org/sites/default/files/docs/usts/USTS-Full-Report-Dec17.pdf [last accessed May 5, 2022].Google Scholar

Pouwels, S, Hageman, D, Gommans, LN, et al. Preoperative exercise therapy in surgical care: a scoping review. J Clin Anesth 2016;33:476–490.Google Scholar

Dronkers, JJ, Chorus, AM, Meeteren, NL, Hopman‐Rock, M. The association of pre‐operative physical fitness and physical activity with outcome after scheduled major abdominal surgery. Anaesthesia 2013;68:67–73.Google Scholar

Mayo, NE, Feldman, L, Scott, S, et al. Impact of preoperative change in physical function on postoperative recovery: argument supporting prehabilitation for colorectal surgery. Surgery 2011;150(3):505–514.CrossRefGoogle ScholarPubMed

Gillis, C, Li, C, Lee, L, et al. Prehabilitation versus rehabilitation. Anesthesiology 2014;121(5):937–947.Google Scholar

Jiang, DD, Gallagher, S, Burchill, L, Berli, J, Dugi, D. Implementation of a pelvic floor physical therapy program for transgender women undergoing gender-affirming vaginoplasty. Obstet Gynecol 2019;133(5):1003–1011.CrossRefGoogle ScholarPubMed

Raphael, KG, Widom, CS. Post-traumatic stress disorder moderates the relation between documented childhood victimization and pain 30 years later. Pain 2011 ;152(1):163–169.Google Scholar

Mazi, B, Kaddour, O, Al-Badr, A. Depression symptoms in women with pelvic floor dysfunction: a case-control study. Int J Womens Health 2019;11:143–148.Google Scholar

Dy, GW, Nolan, IT, Hotaling, J, Myers, JB. Patient reported outcome measures and quality of life assessment in genital gender confirming surgery. Transl Androl Urol 2019;8(3):228–240.CrossRefGoogle ScholarPubMed

Laycock, J. Clinical evaluation of the pelvic floor. In Schussler, B, Laycock, J, Norton, P, Stanton, SL, Eds. Pelvic Floor Re-education. London: Springer-Verlag, 1994, pp. 42–48.Google Scholar

Chevalier, F, Fernandez-Lao, C, Cuesta-Vargas, AI. Normal reference values of strength in pelvic floor muscle of women: a descriptive and inferential study. BMC Womens Health 2014;14:143.Google Scholar

Boden, I, El-Ansary, D, Zalucki, N, et al. Physiotherapy education and training prior to upper abdominal surgery is memorable and has high treatment fidelity: a nested mixed-methods randomised-controlled study. Physiotherapy 2018;104(2):194–202.Google Scholar

Marti, L, Galata, C, Beutner, U, et al. Percutaneous tibial nerve stimulation (pTNS): success rate and the role of rectal capacity. Int J Colorectal Dis 2017;32(6):789–796.Google Scholar

Pedraza, R, Nieto, J, Ibarra, S, Haas, EM. Pelvic muscle rehabilitation: a standardized protocol for pelvic floor dysfunction. Adv Urol 2014;2014:487436. https://doi.org/10.1155/2014/487436Google Scholar

Sakakibara, R, Tsunoyama, K, Hosoi, H, et al. Influence of body position on defecation in humans. Low Urin Tract Symptoms 2010;2(1):16–21.Google Scholar

Scahrdein, JN, Zhao, LC, Nikolavsky, D. Management of vaginoplasty and phalloplasty complications. Urol Clin North Am 2019;46(4):605–618.CrossRefGoogle Scholar

Faubion, SS, Shuster, LT, Bharucha, AE. Recognition and management of nonrelaxing pelvic floor dysfunction. Mayo Clin Proc 2012;87(2):187–193.Google Scholar

Wehbe, SA, Fariello, JY, Whitmore, K. Minimally invasive therapies for chronic pelvic pain syndrome. Curr Urol Rep 2010;11(4):276–285.CrossRefGoogle ScholarPubMed

Bosch, FX, Broker, TR, Forman, D, et al. Comprehensive control of HPV infections and related diseases. Vaccine 2013;31(8):11–31.Google Scholar

Doerfler, D, Bernhaus, A, Kottmel, A, et al. Human papilloma virus infection prior to coitarche. Am J Obstet Gynecol 2009;200(5):487.e1–5.Google Scholar

Giuliano, AR, Lee, JH, Fulp, W, et al. Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. Lancet 2011;377(9769):932–940.Google Scholar

Loverro, G, Di Naro, E, Caringella, AM, et al. Prevalence of human papillomavirus infection in a clinic sample of transsexuals in Italy. Sex Transm Infect 2016;92(1):67–69.Google Scholar

Reisner, SL, Deutsch, MB, Peitzmeier, SM, et al. Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients. PLoS One 2018;13(3):e0190172.CrossRefGoogle ScholarPubMed

Cranston, RD, Carballo-Diéguez, A, Gundacker, H, et al. Prevalence and determinants of anal human papillomavirus infection in men who have sex with men and transgender women. Int J STD AIDS 2019;30(2):154–162.Google Scholar

van der Sluis, WB, Buncamper, ME, Bouman, MB, et al. Prevalence of neovaginal high-risk human papillomavirus among transgender women in the Netherlands. Sex Transm Dis 2016;43(8):503–505.CrossRefGoogle ScholarPubMed

Koutsky, LA, Ault, KA, Wheeler, CM, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002;347(21):1645–1651.Google Scholar

Pils, S, Joura, EA. From the monovalent to the nine-valent HPV vaccine. Clin Microbiol Infect 2015;21(9):827–833.CrossRefGoogle Scholar

Garland, SM, Hernandez-Avila, M, Wheeler, CM, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007;356(19):1928–1943.Google Scholar

Joura, EA, Leodolter, S, Hernandez-Avila, M, et al. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet 2007;369(9574):1693–1702.Google Scholar

Palefsky, JM, Giuliano, AR, Goldstone, S, et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 2011;365(17):1576–1585.Google Scholar

Chaturvedi, AK, Graubard, BI, Broutian, T, et al. Effect of prophylactic human papillomavirus (HPV) vaccination on oral HPV infections among young adults in the United States. J Clin Oncol 2018;36(3):262–267.Google Scholar

Joura, EA, Giuliano, AR, Iversen, OE, et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med 2015;372(8):711–723.Google Scholar

Huh, WK, Joura, EA, Giuliano, AR, et al. Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial. Lancet 2017;390(10108):2143–2159.Google Scholar

Drolet, M, Bénard, É, Pérez, N, Brisson, M, HPV Vaccination Impact Study Group. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet 2019;394(10197):497–509.CrossRefGoogle ScholarPubMed

Castellsagué, X, Muñoz, N, Pitisuttithum, P, et al. End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age. Br J Cancer 2011;105(1):28–37.Google Scholar

Van Damme, P, Meijer, CJ, Kieninger, D, et al. A phase III clinical study to compare the immunogenicity and safety of the 9-valent and quadrivalent HPV vaccines in men. Vaccine 2016;34(35):4205–4212.Google Scholar

Joura, EA, Garland, SM, Paavonen, J, et al. Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data. BMJ 2012;344:e1401.Google Scholar

Jentschke, M, Kampers, J, Becker, J, Sibbertsen, P, Hillemanns, P. Prophylactic HPV vaccination after conization: a systematic review and meta-analysis. Vaccine 2020;38(41):6402–6409.Google Scholar

Ghelardi, A, Marrai, R, Bogani, G, et al. Surgical treatment of vulvar HSIL: adjuvant HPV vaccine reduces recurrent disease. Vaccines (Basel) 2021;9(2):83.CrossRefGoogle ScholarPubMed

Hartwig, S, Baldauf, JJ, Dominiak-Felden, G, et al. Estimation of the epidemiological burden of HPV-related anogenital cancers, precancerous lesions, and genital warts in women and men in Europe: potential additional benefit of a nine-valent second generation HPV vaccine compared to first generation HPV vaccines. Papillomavirus Res 2015;1:90–100.Google Scholar

Garland, SM, Steben, M, Sings, HL, et al. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis 2009;199(6):805–814.Google Scholar

Lacey, CJ, Woodhall, SC, Wikstrom, A, Ross, J. 2012 European guideline for the management of anogenital warts. J Eur Acad Dermatol Venereol 2013;27(3):e263–270.Google Scholar

Matsuki, S, Kusatake, K, Hein, KZ, Anraku, K, Morita, E. Condylomata acuminata in the neovagina after male-to-female reassignment treated with CO2 laser and imiquimod. Int J STD AIDS 2015;26(7):509–511.Google Scholar

Labanca, T, Mañero, I. Vulvar condylomatosis after sex reassignment surgery in a male-to-female transsexual: complete response to imiquimod cream. Gynecol Oncol Rep 2017;20:75–77.Google Scholar

Blomberg, M, Friis, S, Munk, C, Bautz, A, Kjaer, S. Genital warts and risk of cancer: a Danish study of nearly 50 000 patients with genital warts. J Infect Dis 2012;205(10):1544–1553.Google Scholar

US Preventive Services Task Force, Curry, SJ, Krist, AH, et al. Screening for cervical cancer: US preventive services task force recommendation statement. JAMA 2018;320(7):674–686.Google Scholar

Committee Opinion No. 512: Health Care for Transgender Individuals. Obstet Gynecol 2011;118(6):1454–1458.Google Scholar

Rollston, Rebekah. Promoting cervical cancer screening among female-to-male transmasculine patients. The Fenway Institute, 2019. Available at: https://fenwayhealth.org/wp-content/uploads/TFIP-28_TransMenCervicalCancerScreeningBrief_web.pdfGoogle Scholar

McDowell, M, Pardee, DJ, Peitzmeier, S, et al. Cervical cancer screening preferences among trans-masculine individuals: patient-collected human papillomavirus vaginal swabs versus provider-administered pap tests. LGBT Health 2017;4(4):252–259.Google Scholar

Peitzmeier, SM, Khullar, K, Reisner, SL, Potter, J. Pap test use is lower among female-to-male patients than non-transgender women. Am J Prev Med 2014;47(6):808–812.Google Scholar

Peitzmeier, SM, Reisner, SL, Harigopal, P, Potter, J. Female-to-male patients have high prevalence of unsatisfactory Paps compared to non-transgender females: implications for cervical cancer screening. J Gen Intern Med 2014;29(5):778–784.CrossRefGoogle ScholarPubMed

Schenck, TL, Holzbach, T, Zantl, N, et al. Vaginal carcinoma in a female-to-male transsexual. J Sex Med 2010;7(8):2899–2902.Google Scholar

Harder, Y, Erni, D, Banic, A. Squamous cell carcinoma of the penile skin in a neovagina 20 years after male-to-female reassignment. Case Rep Br J Plast Surg 2002;55(5):449–451.Google Scholar

Bollo, J, Balla, A, Rodriguez Luppi, C, et al. HPV-related squamous cell carcinoma in a neovagina after male-to-female gender confirmation surgery. Int J STD AIDS 2018;29(3):306–308.Google Scholar

Fernandes, HM, Manolitsas, TP, Jobling, TW. Carcinoma of the neovagina after male-to-female reassignment. J Low Genit Tract Dis 2014;18(2):E43–45.Google Scholar

Fierz, R, Ghisu, GP, Fink, D. Squamous carcinoma of the neovagina after male-to-female reconstruction surgery: a case report and review of the literature. Case Rep Obstet Gynecol 2019;2019:4820396.Google ScholarPubMed

Wang, G, Ferguson, D, Ionescu, DN, et al. HPV-related neovaginal squamous cell carcinoma presenting as lung metastasis after male-to-female gender confirmation surgery. Case Rep Oncol 2020;13(1):17–22.Google Scholar

Urban, RR, Teng, NN, Kapp, DS. Gynecologic malignancies in female-to-male transgender patients: the need of original gender surveillance. Am J Obstet Gynecol 2011;204(5):e9–e12.Google Scholar

Driák, D, Samudovský, M. Could a man be affected with carcinoma of cervix? The first case of cervical carcinoma in trans-sexual person (FtM): case report. Acta Medica (Hradec Kralove) 2005;48(1):53–55.Google Scholar

van der Sluis, WB, Buncamper, ME, Bouman, MB, et al. Symptomatic HPV-related neovaginal lesions in transgender women: case series and review of literature. Sex Transm Infect 2016;92(7):499–501.Google Scholar

Baral, SD, Poteat, T, Strömdahl, S, et al. Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis 2013 (online). https://doi.org/10.1016/S1473-3099(12)70315-8Google Scholar

Frank, TD, Carter, A, Jahagirdar, D, et al. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. Lancet HIV 2019 (online). https://doi.org/10.1016/S2352-3018(19)30196-1Google Scholar

Becasen, JS, Denard, CL, Mullins, MM, Higa, DH, Sipe, TA. Estimating the prevalence of HIV and sexual behaviors among the US transgender population: a systematic review and meta-analysis, 2006–2017. Am J Public Health 2019 (online). https://doi.org/10.2105/AJPH.2018.304727Google Scholar

UNAIDS. Global HIV and AIDS statistics 2019 Fact sheet. Published 2019.Google Scholar

Bukowski, LA, Chandler, CJ, Creasy, SL, et al. Characterizing the HIV care continuum and identifying barriers and facilitators to HIV diagnosis and viral suppression among black transgender women in the United States. J Acquir Immune Defic Syndr 2018 (online). https://doi.org/10.1097/QAI.0000000000001831Google Scholar

Jobson, G, Tucker, A, de Swardt, G, et al. Gender identity and HIV risk among men who have sex with men in Cape Town, South Africa. AIDS Care - Psychol Socio-Medical Asp AIDS/HIV. Published 2018. https://doi.org/10.1080/09540121.2018.1465175Google Scholar

Para, AJ, Gee, SE, Davis, JA. Sexually transmitted infections in LGBT populations. Lesbian Gay Bisexual Transgend Healthcare 2016 (online). https://doi.org/10.1007/978-3-319-19752-4_14Google Scholar

Borda, LJ, Perper, M, Keri, JE. Treatment of seborrheic dermatitis: a comprehensive review. J Dermatolog Treat 2019 (online). https://doi.org/10.1080/09546634.2018.1473554Google Scholar

Chu, C, Selwyn, PA. Diagnosis and initial management of acute HIV infection. Am Fam Physician 2010;81(10):1239–1244.Google Scholar

Wood, SM, Salas-Humara, C, Dowshen, NL. Human immunodeficiency virus, other sexually transmitted infections, and sexual and reproductive health in lesbian, gay, bisexual, transgender youth. Pediatr Clin North Am 2016 (online). https://doi.org/10.1016/j.pcl.2016.07.006Google Scholar

World Health Organization. WHO guidelines for the treatment of genital herpes simplex virus. Published 2016.Google Scholar

Van Gerwen, OT, Jani, A, Long, DM, et al. Prevalence of sexually transmitted infections and human immunodeficiency virus in transgender persons: a systematic review. Transgend Health 2020 (online). https://doi.org/10.1089/trgh.2019.0053Google Scholar

Elfering, L, van der Sluis, WB, Mermans, JF, Buncamper, ME. Herpes neolabialis: herpes simplex virus type 1 infection of the neolabia in a transgender woman. Int J STD AIDS 2017 (online). https://doi.org/10.1177/0956462416685658CrossRefGoogle Scholar

Singh, V, Gratzer, B, Gorbach, PM, et al. Transgender women have higher human papillomavirus prevalence than men who have sex with men: two U.S. Cities, 2012–2014. Sex Transm Dis 2019 (online). https://doi.org/10.1097/OLQ.0000000000001051Google Scholar

Workowski, KA, Bolan, GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Reports 2015 (online). https://doi.org/10.1016/j.annemergmed.2015.07.526Google Scholar

van der Sluis, WB, Bouman, MB, Gijs, L, van Bodegraven, AA. Gonorrhoea of the sigmoid neovagina in a male-to-female transgender. Int J STD AIDS 2015 (online). https://doi.org/10.1177/0956462414544725Google Scholar

Yunihastuti, E, Teeratakulpisarn, N, Jeo, WS, et al. Incidence, clearance, persistence and factors related with high-risk anal HPV persistence in South-East Asian MSM and transgender women. AIDS 2020 (online). https://doi.org/10.1097/QAD.0000000000002654Google Scholar

Sullivan, PS, Phaswana-Mafuya, N, Baral, SD, et al. HIV prevalence and incidence in a cohort of South African men and transgender women who have sex with men: the Sibanye Methods for Prevention Packages Programme (MP3) project. J Int AIDS Soc 2020 (online). https://doi.org/10.1002/jia2.25591Google Scholar

Pathela, P, Blank, S, Schillinger, JA. Lymphogranuloma venereum: old pathogen, new story. Curr Infect Dis Rep 2007 (online). https://doi.org/10.1007/s11908-007-0010-7Google Scholar

Radix, AE, Harris, AB, Belkind, U, Ting, J, Goldstein, ZG. Chlamydia trachomatis infection of the neovagina in transgender women. Open Forum Infect Dis 2019 (online). https://doi.org/10.1093/ofid/ofz470CrossRefGoogle Scholar

World Health Organization. WHO 2016 Treatment of Syphilis Guidelines. Published 2016.Google Scholar

Stephens, SC, Bernstein, KT, Philip, SS. Male to female and female to male transgender persons have different sexual risk behaviors yet similar rates of STDs and HIV. AIDS Behav 2011 (online). https://doi.org/10.1007/s10461-010-9773-1Google Scholar

Fernandes, FRP, Zanini, PB, Rezende, GR, et al. Syphilis infection, sexual practices and bisexual behaviour among men who have sex with men and transgender women: a cross-sectional study. Sex Transm Infect 2015 (online). https://doi.org/10.1136/sextrans-2014-051589Google Scholar

Soper, DE, Bump, RC, Hurt, WG. Bacterial vaginosis and trichomoniasis vaginitis are risk factors for cuff cellulitis after abdominal hysterectomy. Am J Obstet Gynecol 1990;163(3):1013–1016. https://doi.org/10.1016/0002-9378(90)91115-sGoogle Scholar

Sevelius, J. “There’s no pamphlet for the kind of sex I have”: HIV-related risk factors and protective behaviors among transgender men who have sex with nontransgender men. J Assoc Nurses AIDS Care 2009 (online). https://doi.org/10.1016/j.jana.2009.06.001Google Scholar

Herbst, JH, Jacobs, ED, Finlayson, TJ, et al. Estimating HIV prevalence and risk behaviors of transgender persons in the United States: a systematic review. AIDS Behav 2008 (online). https://doi.org/10.1007/s10461-007-9299-3Google Scholar

Clements-Nolle, K, Marx, R, Guzman, R, Katz, M. HIV prevalence, risk behaviors, health care use, and mental health status of transgender persons: implications for public health intervention. Am J Public Health 2001 (online). https://doi.org/10.2105/AJPH.91.6.915Google Scholar

Callander, D, Cook, T, Read, P, et al. Sexually transmissible infections among transgender men and women attending Australian sexual health clinics. Med J Aust 2019 (online). https://doi.org/10.5694/mja2.50322Google Scholar

Drückler, S, Daans, C, Hoornenborg, E, et al. HIV and STI positivity rates among transgender people attending two large STI clinics in the Netherlands. Sex Transm Infect 2021 (online). https://doi.org/10.1136/sextrans-2020-054875Google Scholar

Castillo, R, Konda, KA, Leon, SR, et al. HIV and sexually transmitted infection incidence and associated risk factors among high-risk MSM and male-to-female transgender women in Lima, Peru. J Acquir Immune Defic Syndr 2015 (online). https://doi.org/10.1097/QAI.0000000000000667Google Scholar

Shover, CL, DeVost, MA, Beymer, MR, et al. Using sexual orientation and gender identity to monitor disparities in HIV, sexually transmitted infections, and viral hepatitis. Am J Public Health 2018 (online). https://doi.org/10.2105/AJPH.2018.304751Google Scholar

Sahastrabuddhe, S, Gupta, A, Stuart, E, et al. Sexually transmitted infections and risk behaviors among transgender persons (Hijras) of Pune, India. J Acquir Immune Defic Syndr 2012 (online). https://doi.org/10.1097/QAI.0b013e318236bd6fGoogle Scholar

Kojima, N, Park, H, Konda, KA, et al. The PICASSO Cohort: baseline characteristics of a cohort of men who have sex with men and male-to-female transgender women at high risk for syphilis infection in Lima, Peru. BMC Infect Dis 2017 (online). https://doi.org/10.1186/s12879-017-2332-xGoogle Scholar

Galea, JT, Kinsler, JJ, Galan, DB, et al. Factors associated with visible anogenital warts among HIV-uninfected Peruvian men who have sex with men and transwomen: a cross-sectional study. Sex Transm Dis 2015 (online). https://doi.org/10.1097/OLQ.0000000000000253Google Scholar

Buchbinder, SP, Glidden, DV, Liu, AY, et al. HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial. Lancet Infect Dis 2014 (online). https://doi.org/10.1016/S1473-3099(14)70025-8Google Scholar

Reisner, SL, Vetters, R, White, JM, et al. Laboratory-confirmed HIV and sexually transmitted infection seropositivity and risk behavior among sexually active transgender patients at an adolescent and young adult urban community health center. AIDS Care - Psychol Socio-Medical Asp AIDS/HIV 2015 (online). https://doi.org/10.1080/09540121.2015.1020750Google Scholar

Reisner, SL, White Hughto, JM, Pardee, D, Sevelius, J. Syndemics and gender affirmation: HIV sexual risk in female-to-male trans masculine adults reporting sexual contact with cisgender males. Int J STD AIDS 2016 (online). https://doi.org/10.1177/0956462415602418Google Scholar

Nuttbrock, L, Hwahng, S, Bockting, W, et al. Lifetime risk factors for HIV/sexually transmitted infections among male-to-female transgender persons. J Acquir Immune Defic Syndr 2009 (online). https://doi.org/10.1097/QAI.0b013e3181ab6ed8Google Scholar

Operario, D, Nemoto, T. HIV in transgender communities: syndemic dynamics and a need for multicomponent interventions. J Acquir Immune Defic Syndr 2010 (online). https://doi.org/10.1097/QAI.0b013e3181fbc9ecGoogle Scholar

Gandhi, M, Spinelli, MA, Mayer, KH. Addressing the sexually transmitted infection and HIV syndemic. JAMA 2019 (online). https://doi.org/10.1001/jama.2019.2945Google Scholar

Brennan, J, Kuhns, LM, Johnson, AK, et al. Syndemic theory and HIV-related risk among young transgender women: the role of multiple, co-occurring health problems and social marginalization. Am J Public Health 2012 (online). https://doi.org/10.2105/AJPH.2011.300433Google Scholar

Neumann, MS, Finlayson, TJ, Pitts, NL, Keatley, JA. Comprehensive HIV prevention for transgender persons. Am J Public Health 2017 (online). https://doi.org/10.2105/AJPH.2016.303509Google Scholar

Meyer, IH. Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: conceptual issues and research evidence. Psychol Bull 2003 (online). https://doi.org/10.1037/0033-2909.129.5.674Google Scholar

Hendricks, ML, Testa, RJ. A conceptual framework for clinical work with transgender and gender nonconforming clients: an adaptation of the minority stress model. Prof Psychol Res Pract 2012 (online). https://doi.org/10.1037/a0029597Google Scholar

Risser, JMH, Shelton, A, McCurdy, S, et al. Sex, drugs, violence, and HIV status among male-to-female transgender persons in Houston, Texas. Int J Transgenderism 2005 (online). https://doi.org/10.1300/J485v08n02_07Google Scholar

Bockting, W, Avery, E. Transgender health and HIV prevention: needs assessment studies from transgender communities across the United States – Introduction. Int J Transgenderism 2005 (online). https://doi.org/10.1300/J485v08n02_01Google Scholar

Thompson, LH, Dutta, S, Bhattacharjee, P, et al. Violence and mental health among gender-diverse individuals enrolled in a human immunodeficiency virus program in Karnataka, South India. Transgend Health 2019 (online). https://doi.org/10.1089/trgh.2018.0051CrossRefGoogle Scholar

Bukowski, LA, Hampton, MC, Escobar-Viera, CG, et al. Intimate partner violence and depression among Black transgender women in the USA: the potential suppressive effect of perceived social support. J Urban Health 2019 (online). https://doi.org/10.1007/s11524-019-00355-3Google Scholar

Sugano, E, Nemoto, T, Operario, D. The impact of exposure to transphobia on HIV risk behavior in a sample of transgendered women of color in San Francisco. AIDS Behav 2006 (online). https://doi.org/10.1007/s10461-005-9040-zGoogle Scholar

Operario, D, Nemoto, T. Sexual risk behavior and substance use among a sample of Asian Pacific Islander transgendered women. AIDS Educ Prev 2005 (online). https://doi.org/10.1521/aeap.2005.17.5.430Google Scholar

Wilson, EC, Garofalo, R, Harris, RD, et al. Transgender female youth and sex work: HIV risk and a comparison of life factors related to engagement in sex work. AIDS Behav 2009 (online). https://doi.org/10.1007/s10461-008-9508-8Google Scholar

Poteat, T, Scheim, A, Xavier, J, Reisner, S, Baral, S. Global epidemiology of HIV infection and related syndemics affecting transgender people. J Acquir Immune Defic Syndr 2016 (online). https://doi.org/10.1097/QAI.0000000000001087CrossRefGoogle Scholar

Reisner, SL, Jadwin-Cakmak, L, White Hughto, JM, et al. Characterizing the HIV prevention and care continua in a sample of transgender youth in the U.S. AIDS Behav 2017 (online). https://doi.org/10.1007/s10461-017-1938-8Google Scholar

Reback, CJ, Simon, P. The Los Angeles transgender health study: creating a research and community collaboration. Preventing AIDS: Community-Science Collaborations 2012 (online). https://doi.org/10.4324/9780203048306Google Scholar

Hoagland, B, Moreira, RI, De Boni, RB, et al. High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project. J Int AIDS Soc 2017 (online). https://doi.org/10.7448/IAS.20.1.21472Google Scholar

Chakrapani, V, Shunmugam, M, Rawat, S, et al. Acceptability of HIV pre-exposure prophylaxis among transgender women in India: a qualitative investigation. AIDS Patient Care STDS 2020 (online). https://doi.org/10.1089/apc.2019.0237Google Scholar

Socías, ME, Marshall, BDL, Arístegui, I, et al. Factors associated with healthcare avoidance among transgender women in Argentina. Int J Equity Health 2014 (online). https://doi.org/10.1186/s12939-014-0081-7Google Scholar

Sevelius, JM, Patouhas, E, Keatley, JG, Johnson, MO. Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus. Ann Behav Med 2014 (online). https://doi.org/10.1007/s12160-013-9565-8Google Scholar

Legal, L. When healthcare isn’t caring: Lambda Legal’s survey on discrimination against LGBT people and people living with HIV. Published 2010. Available at: www.lambdalegal.org/publications/when-health-care-isnt-caring.Google Scholar

Kammerer, N, Mason, T, Connors, M, et al. Transgenders, HIV/AIDS, and substance abuse: from risk group to group prevention. In Bockting, W, Kirk, S, Eds. Transgender & HIV: Risks, Prevention & Care. Binghampton, NY: The Haworth Press, 2001.Google Scholar

Kammerer, N, Mason, T, Connors, M, et al. Transgender health and social service needs in the context of HIV risk. In Bockting, W, Kirk, S, Eds. Transgender & HIV: Risks, Prevention & Care. Binghampton, NY: The Haworth Press, 2001.Google Scholar

Kenagy, GP. HIV among transgendered people. AIDS Care - Psychol Socio-Medical Asp AIDS/HIV 2002 (online). https://doi.org/10.1080/09540120220098008Google Scholar

Baguso, GN, Turner, CM, Santos, GM, et al. Successes and final challenges along the HIV care continuum with transwomen in San Francisco. J Int AIDS Soc 2019 (online). https://doi.org/10.1002/jia2.25270Google Scholar

Longman Marcellin, R, Bauer, GR, Scheim, AI. Intersecting impacts of transphobia and racism on HIV risk among trans persons of colour in Ontario, Canada. Ethn Inequalities Heal Soc Care 2013 (online). https://doi.org/10.1108/EIHSC-09-2013-0017Google Scholar

Ackerley, CG, Billingsley, JM, Tharp, GK, et al. Short communication:transgender women on feminizing hormone therapy demonstrate a distinct rectal mucosal transcriptome from cisgender men. AIDS Res Hum Retroviruses 2020 (online). https://doi.org/10.1089/aid.2020.0061Google Scholar

Shieh, E, Marzinke, MA, Fuchs, EJ, et al. Transgender women on oral HIV pre-exposure prophylaxis have significantly lower tenofovir and emtricitabine concentrations when also taking oestrogen when compared to cisgender men. J Int AIDS Soc 2019 (online). https://doi.org/10.1002/jia2.25405Google Scholar

Hiransuthikul, A, Janamnuaysook, R, Himmad, K, et al. Drug-drug interactions between feminizing hormone therapy and pre-exposure prophylaxis among transgender women: the iFACT study. J Int AIDS Soc 2019 (online). https://doi.org/10.1002/jia2.25338Google Scholar

Thomas, R, Pega, F, Khosla, R, et al. Ensuring an inclusive global health agenda for transgender people. Bull World Health Organ 2017 (online). https://doi.org/10.2471/BLT.16.183913Google Scholar

Center of Excellence for Transgender Health. Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People. Published 2016. University of California, San Francisco.Google Scholar

Peitzmeier, SM, Reisner, SL, Harigopal, P, Potter, J. Female-to-male patients have high prevalence of unsatisfactory Paps compared to non-transgender females: implications for cervical cancer screening. J Gen Intern Med 2014 (online). https://doi.org/10.1007/s11606-013-2753-1Google Scholar

Reisner, SL, Deutsch, MB, Peitzmeier, SM, et al. Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients. PLoS One 2018 (online). https://doi.org/10.1371/journal.pone.0190172Google Scholar

U.S. Food and Drug Administration. FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic. Case Med Res 2019 (online). https://doi.org/10.31525/cmr-1e4dc7dGoogle Scholar

U.S. Food and Drug Administration. FDA approves first drug for reducing the risk of sexually acquired HIV infection. FDA Press Announcements.Google Scholar

UCSF Transgender Care Department of Family and Community Medicine, University of California San Francisco. Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People. University of California, San Francisco.Google Scholar

Gelman, M, van Wagenen, APJ. Principles for taking an LGBTQ-inclusive health history and conducting a culturally competent physical exam. In Makadon, H, Potter, J, Mayer, K, Goldhammer, H, Eds. Fenway Guide to Lesbian, Gay, Bisexual, and Transgender Health (2nd ed.). American College of Physicians, 2015, pp. 159–192.Google Scholar

Grant, JM, Mottet, LA, Tanis, J, et al. Injustice at Every Turn: A Report of the National Transgender Discrimination Survey. Washington National Center for Transgender Equality National Gay Lesbian Task Force. Published 2011. https://doi.org/10.1016/S0016-7878(90)80026-2Google Scholar

Substance Abuse and Mental Health Services Administration. SAMHSA’s concept of trauma and guidance for a trauma-informed approach. HHS Publication no. (SMA) 14-4884. Published 2014.Google Scholar

Meites, E, Szilagyi, PG, Chesson, HW, et al. Human papillomavirus vaccination for adults: updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 2019 (online). https://doi.org/10.15585/mmwr.mm6832a3Google Scholar

Dubin, SN, Nolan, IT, Streed, CG Jr, et al. Transgender health care: improving medical students’ and residents’ training and awareness. Adv Med Educ Pract 2018 (online). https://doi.org/10.2147/amep.s147183Google Scholar

Deutsch, MB, Glidden, DV, Sevelius, J, et al. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial. Lancet HIV 2015 (online). https://doi.org/10.1016/S2352-3018(15)00206-4Google Scholar

Dhillon, N, Oliffe, JL, Kelly, MT, Krist, J. Bridging barriers to cervical cancer screening in transgender men: a scoping review. Am J Mens Health 2020;14(3):1557988320925691. https://doi.org/10.1177/1557988320925691Google Scholar

McDowell, M, Pardee, DJ, Peitzmeier, S, et al. Cervical cancer screening preferences among trans-masculine individuals: patient-collected human papillomavirus vaginal swabs versus provider-administered pap tests. LGBT Health 2017;4(4):252–259.Google Scholar

Arbyn, M, Weiderpass, E, Bruni, L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Global Health 2020;8(2): e191–e203.Google Scholar

de Martel, C, Plummer, M, Vignat, J, et al. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer 2017;141(4):664–670.Google Scholar

Safaeian, M, Solomon, D, Castle, PE. Cervical cancer prevention – cervical screening: science in evolution. Obstet Gynecol Clin North Am 2007;34(4):739–760. https://doi.org/10.1016/j.ogc.2007.09.004Google Scholar

Koh, W-J, Abu-Rustum, NR, Bean, S, et al. Cervical cancer, version 3.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 2019;17(1):64–84.Google Scholar

Curry, SJ, Krist, AH, Owens, DK, et al. Screening for cervical cancer: US Preventive Services Task Force recommendation statement. JAMA 2018;320(7): 674–686.Google Scholar

Reisner, SL, Deutsch, MB, Peitzmer, SM, et al. Comparing self- and provider-collected swabbing for HPV DNA testing in female-to-male transgender adult patients: a mixed-methods biobehavioral study protocol. BMC Infect Dis 2017;17:444.Google Scholar

Loughlin, KR. Cancer risk in the transgender community. Lancet Onc 2015;16(9):999.Google Scholar

Seay, J, Ranck, A, Weiss, R, et al. Understanding transgender men’s experiences with and preferences for cervical cancer screening: a rapid assessment survey. LGBT Health 2017;4(4):304–309.Google Scholar

American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 463: cervical cancer in adolescents: screening, evaluation, and management. Obstet Gynecol 2010;116(2 Pt 1):469–472.Google Scholar

Perkins, RB, Guido, RS, Castle, PE, et al. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis 2020;24(2):102.Google Scholar

Cooper, DB, Goyal, M. Colposcopy. StatPearls(online) 2020. See: www.ncbi.nlm.nih.gov/books/NBK564514/Google Scholar

Patel, JM, Dolitsky, S, Bachman, GA, et al. Gynecologic cancer screening in the transgender male population and its current challenges. Maturitas 2019;129:40–44.Google Scholar

Grynberg, M, Fanchin, R, Dubost, G, et al. Histology of genital tract and breast tissue after long-term testosterone administration in a female-to-male transsexual population. Reprod Biomed Online 2010;20(4):553–558.Google Scholar

Reisner, SL, Deutsch, MB, Peitzmeier, SM, et al. Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients. PLoS One 2018;13(3):e0190172.Google Scholar

Wright, TC Jr, Denny, L, Kuhn, L, Pollack, A, Lorincz, A. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 2000;283(1):81–86. https://doi.org/10.1001/jama.283.1.81Google Scholar

Greer, BE, Koh, WJ. New NCCN guidelines for vulvar cancer. J Natl Compr Canc Netw 2016; 14(5S):656–658.Google Scholar

Grosse, A, Grosse, C, Lenggenhager, D, et al. Cytology of the neovagina in transgender women and individuals with congenital or acquired absence of a natural vagina. Cytopathology 2017;28(3):184–191.Google Scholar

Van Damme, P, Olsson, SE, Block, S, et al. Immunogenicity and safety of a 9-valent HPV vaccine. Pediatrics 2015;136(1):e28–e39.Google Scholar

Pils, S, Joura, EA. From the monovalent to the nine-valent HPV vaccine. Clin Microbiol Infect 2015;21(9):827–833.Google Scholar